Yahoo Web Search

  1. Novartis' (NVS) Wet AMD Drug Beovu Obtains FDA Approval

    Zacks via Yahoo FinanceOct 09 15:10 PM

    Swiss pharma giant Novartis AG NVS announced that the FDA approved its ophthalmology drug Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration ...

  2. Factors Setting the Tone for Novartis' (NVS) Q3 Earnings

    Zacks via Yahoo FinanceOct 18 14:21 PM

    Swiss pharma giant Novartis AG NVS is scheduled to report third-quarter 2019 results on Oct 22. The company is scheduled to release results on Oct 29.

  3. This week, the FDA approved Novartis' NVS potential blockbuster eye drug, Beovu. J&J JNJ submitted a regulatory application seeking label expansion approval of its plaque psoriasis drug ...

  4. Novartis' Jakavi Meets Primary Goal in Phase III for GVHD

    Zacks via Yahoo FinanceOct 17 16:12 PM

    Novartis AG NVS announced that the phase III REACH2 study, which evaluated Jakavi (ruxolitinib) for treating patients with steroid-refractory acute graft-versus-host disease (GVHD ...

  5. Pfenex Inc (NYSE: PFNX) has a key binary event coming up: mark your calendar for Oct. 7, when the FDA is scheduled to issue its verdict on the company's lead drug candidate. Through its production ...

  6. Biotechnologies Corp (NASDAQ: ADPT) Aduro BioTech Inc (NASDAQ: ADRO) Akcea Therapeutics Inc (NASDAQ: AKCA) Albireo Pharma Inc (NASDAQ: ALBO) Alkermes Plc (NASDAQ: ALKS) AnaptysBio Inc ...

  7. The recent FDA approval of Novartis AG’s NVS Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD) has put the spotlight on this promising ...

  8. This week marked the start of the third-quarter earnings season for the pharma space with J&J JNJ releasing its earnings. Roche RHHBY reported sales results for the first nine months ...

  9. Recap of the Week's Most Important Stories FDA Approves Novartis' New Eye Drug:The FDA granted approval to Novartis' ophthalmology drug, Beovu (brolucizumab) injection to treat ...

  10. Roche Boosts Outlook for Third Time as New Drugs Surge

    Bloomberg via Yahoo FinanceOct 16 7:01 AM

    Roche Holding AG for the third time this year said sales and profit may be better than expected as its push outside cancer pays off.Sales and core earnings per share will rise by a percentage ...